HRMY earnings call for the period ending September 30, 2024.
HRMY earnings call for the period ending June 30, 2024.
HRMY earnings call for the period ending March 31, 2024.
HRMY earnings call for the period ending December 31, 2023.
The commercial-stage company was dinged by a bearish new take from a researcher.
Leveraging a favorable DEA classification for its synthetic analog of THC, Mira Pharmaceuticals could be on an expedited pathway toward commercialization to treat several unmet neurological m
HRMY earnings call for the period ending September 30, 2023.
/PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and...
Stocks that traded heavily or had substantial price changes on Friday: Wells Fargo, JPMorgan Chase rise; Harmony Biosciences, Belden fall
The company reported underwhelming phase 3 trial results for Pitolisant to treat idiopathic hypersomnia.